Osaka University · Faculty of Medicine / Graduate School of Medical Sciences

Research keywordsWT1ペプチドワクチン・樹状細胞ワクチン・がん免疫療法・CTL応答・CAR-T細胞・悪性胸膜中皮腫・膠芽腫・養子免疫療法

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.2025 · Journal for immunotherapy of cancer Vol. 13 No. 7 2025年7月31日 研究論文（学術雑誌）
• WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.2025 · Journal of hematology & oncology Vol. 18 No. 1 p. 9-9 2025年1月23日
• Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.2025 · Journal of hematology & oncology Vol. 18 No. 1 p. 34-34 2025年3月19日
• Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumor.2024 · Cancer immunology, immunotherapy : CII Vol. 74 No. 1 p. 15-15 2024年11月7日 研究論文（学術雑誌）

• Official profile